Key facts
- XP Health’s last known valuation is $120.0M.
- It has raised $55.4M; the latest was Later Stage VC ($33.2M) in Sep 2024.
- Notable investors include Plug and Play Tech Center, StartX (US), Village Global, QED Investors, GSR Ventures — 38 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for XP Health
- ·The full record, as it builds
Funding rounds
No funding rounds for XP Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About XP Health
Developer of an artificial intelligence-powered vision benefits platform designed to take care of human sight. The company's platform uses augmented reality, customer-centric design, and care navigation to offer a vision care platform that is a virtual-first approach for eye care and eyewear that allows one to find in-person eye exams, take an online vision acuity test to renew prescriptions online and find personalized glasses, enabling employees and their families to access to omprehensive vision care at significantly lower costs while expanding their coverage.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Founded
- 2018
- Employees
- 70
- Website
- xphealth.co/
- Ownership
- Privately Held (backing)
XP Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in XP Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on XP Health in its N-PORT filings yet. We sweep new filings monthly.